American Heart Journal
Volume 150, Issue 4 , Pages 666-673 , October 2005

Predictive power of ejection fraction and renal failure in patients admitted for chest pain without ST elevation in the troponin era

  • Michael C. Kontos, MD

      Affiliations

    • Cardiology Division, Department of Internal Medicine, Virginia Commonwealth University, Richmond, Va
    • Department of Emergency Medicine, Virginia Commonwealth University, Richmond, Va
    • Department of Radiology, Virginia Commonwealth University, Richmond, Va
    • Corresponding Author InformationReprint requests: Michael C. Kontos, MD, Room 7-074, Heart Station, North Hospital, PO Box 980051, Medical College of Virginia, 12th and 1300 E. Marshall Sts, Richmond, VA 23298-0051.
    • ,
  • Rajat Garg, MD

      Affiliations

    • Cardiology Division, Department of Internal Medicine, Virginia Commonwealth University, Richmond, Va
    • ,
  • F. Philip Anderson, PhD

      Affiliations

    • Clinical Chemistry Division, Department of Pathology, Virginia Commonwealth University, Richmond, Va
    • ,
  • James L. Tatum, MD

      Affiliations

    • Department of Radiology, Virginia Commonwealth University, Richmond, Va
    • ,
  • Joseph P. Ornato, MD

      Affiliations

    • Department of Emergency Medicine, Virginia Commonwealth University, Richmond, Va
    • ,
  • Robert L. Jesse, MD, PhD

      Affiliations

    • Cardiology Division, Department of Internal Medicine, Virginia Commonwealth University, Richmond, Va

Received 28 June 2004 ,Accepted 9 December 2004.

References 

  1. Risk stratification and survival after myocardial infarction. N Engl J Med. 1983;309:331–336
  2. Zaret BL, Wackers FJ, Terrin ML, et al. Value of radionuclide rest and exercise left ventricular ejection fraction in assessing survival of patients after thrombolytic therapy for acute myocardial infarction: results of Thrombolysis in Myocardial Infarction (TIMI) phase II study. The TIMI Study Group. J Am Coll Cardiol. 1995;26:73–79
  3. Nicolosi GL, Latini R, Marino P, et al. The prognostic value of predischarge quantitative two-dimensional echocardiographic measurements and the effects of early lisinopril treatment on left ventricular structure and function after acute myocardial infarction in the GISSI-3 Trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. Eur Heart J. 1996;17:1646–1656
  4. McCullough PA, Soman SS, Shah SS, et al. Risks associated with renal dysfunction in patients in the coronary care unit. J Am Coll Cardiol. 2000;36:679–684
  5. Santopinto JJ, Fox KA, Goldberg RJ, et al. Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: findings from the global registry of acute coronary events (GRACE). Heart. 2003;89:1003–1008
  6. Al Suwaidi J, Reddan DN, Williams K, et al. Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation. 2002;106:974–980
  7. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. The PURSUIT Trial Investigators. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrillin Therapy. N Engl J Med. 1998;339:436–443
  8. Low-molecular-weight heparin during instability in coronary artery disease, Fragmin during Instability in Coronary Artery Disease (FRISC) study group. Lancet. 1996;347:561–568
  9. Lindahl B, Venge P, Wallentin L. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. The FRISC study group. Circulation. 1996;93:1651–1657
  10. Morrow DA, Cannon CP, Rifai N, et al. Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non–ST elevation myocardial infarction. JAMA. 2001;286:2405–2412
  11. Alpert JS, Thygesen K, Bassand JP, et al. Myocardial infarction redefined—a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of Myocardial Infarction. J Am Coll Cardiol. 2000;36:959–969
  12. Tatum JL, Jesse RL, Kontos MC, et al. Comprehensive strategy for the evaluation and triage of the chest pain patient. Ann Emerg Med. 1997;29:116–123
  13. Kontos MC, Shah R, Fritz LM, et al. Implication of different cardiac troponin I levels for clinical outcomes and prognosis of acute chest pain patients. J Am Coll Cardiol. 2004;43:958–965
  14. Germano G, Kiat H, Kavanagh PB, et al. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med. 1995;36:2138–2147
  15. Kontos MC, Kurdziel K, McQueen R, et al. Comparison of 2-dimensional echocardiography and myocardial perfusion imaging for diagnosing myocardial infarction in emergency department patients. Am Heart J. 2002;143:659–667
  16. Levey AS, Coresh J, Balk E, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003;139:137–147
  17. Hasdai D, Topol EJ, Kilaru R, et al. Frequency, patient characteristics, and outcomes of mild-to-moderate heart failure complicating ST-segment elevation acute myocardial infarction: lessons from 4 international fibrinolytic therapy trials. Am Heart J. 2003;145:73–79
  18. Burns RJ, Gibbons RJ, Yi Q, et al. The relationships of left ventricular ejection fraction, end-systolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis. J Am Coll Cardiol. 2002;39:30–36
  19. Singh M, Reeder GS, Jacobsen SJ, et al. Scores for post-myocardial infarction risk stratification in the community. Circulation. 2002;106:2309–2314
  20. Krumholz HM, Chen J, Chen YT, et al. Predicting one-year mortality among elderly survivors of hospitalization for an acute myocardial infarction: results from the Cooperative Cardiovascular Project. J Am Coll Cardiol. 2001;38:453–459
  21. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. The SOLVD Investigators. N Engl J Med. 1992;327:685–691
  22. Yusuf S, Pfeffer MA, Swedberg K, et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet. 2003;362:777–781
  23. Gottlieb S, Moss AJ, McDermott M, et al. Interrelation of left ventricular ejection fraction, pulmonary congestion and outcome in acute myocardial infarction. Am J Cardiol. 1992;69:977–984
  24. Wright RS, Reeder GS, Herzog CA, et al. Acute myocardial infarction and renal dysfunction: a high-risk combination. Ann Intern Med. 2002;137:563–570
  25. Gibson CM, Pinto DS, Murphy SA, et al. Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality. J Am Coll Cardiol. 2003;42:1535–1543
  26. Sadeghi HM, Stone GW, Grines CL, et al. Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction. Circulation. 2003;108:2769–2775
  27. Sorensen CR, Brendorp B, Rask-Madsen C, et al. The prognostic importance of creatinine clearance after acute myocardial infarction. Eur Heart J. 2002;23:948–952
  28. Antman EM, Cohen M, Bernink PJLM, et al. The TIMI risk score for unstable angina/non–ST elevation MI. A method for prognostication and therapeutic decision making. JAMA. 2000;284:835–842
  29. Boersma E, Pieper KS, Steyerberg EW, et al. Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. Circulation. 2000;101:2557–2567
  30. Granger CB, Goldberg RJ, Dabbous O, et al. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med. 2003;163:2345–2353
  31. Lindahl B, Diderholm E, Lagerqvist B, et al. Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease: a FRISC II substudy. J Am Coll Cardiol. 2001;38:979–986
  32. Antman EM, McCabe CH, Gurfinkel EP, et al. Enoxaparin prevents death and cardiac ischemic events in unstable angina/non–Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial. Circulation. 1999;100:1593–1601
  33. Apple FS, Murakami M, Panteghini M, et al. International survey on the use of cardiac markers. Clin Chem. 2001;47:587–588

PII: S0002-8703(04)00907-X

doi: 10.1016/j.ahj.2004.12.007

American Heart Journal
Volume 150, Issue 4 , Pages 666-673 , October 2005

Article Tools

* Image Usage & Resolution